MicroRNAs in renal cell carcinoma: Diagnostic implications of serum miR-1233 levels

PLoS ONE

Volumn 6, Issue 9, 2011, Pages

  Wulfken, Lena M ^a   Moritz, Rudolf ^b   Ohlmann, Carsten ^c   Holdenrieder, Stefan ^a   Jung, Volker ^c   Becker, Frank ^c,d   Herrmann, Edwin ^b   Walgenbach Brünagel, Gisela ^d   von Ruecker, Alexander ^a   Müller, Stefan C ^a   Ellinger, Jörg ^a  

^a UNIVERSITY HOSPITAL BONN   (Germany)

^b UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^c SAARLAND UNIVERSITY   (Germany)

^d Urologische Gemeinschaftspraxis und Ambulatorium Derouet/Poenicke/Becker   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 106B; MICRORNA 1233; MICRORNA 1290; MICRORNA 210; MICRORNA 320B; MICRORNA 7 1; MICRORNA 93; UNCLASSIFIED DRUG;

ADULT; AGED; ANGIOLIPOMA; ARTICLE; BLOOD LEVEL; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GENE EXPRESSION; HUMAN; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; ONCOCYTOMA; SENSITIVITY AND SPECIFICITY; UPREGULATION; VALIDATION STUDY; BLOOD; MIDDLE AGED; REAL TIME POLYMERASE CHAIN REACTION;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, RENAL CELL; FEMALE; HUMANS; MALE; MICRORNAS; MIDDLE AGED; REAL-TIME POLYMERASE CHAIN REACTION; YOUNG ADULT;

EID: 80053586899     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0025787     Document Type: Article

References (32)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, et al. (2011) Global cancer statistics. CA Cancer J Clin 61: 69-90.
2. Ljungberg B, Cowan NC, Hanbury DC, Hora M, Kuczyk MA, et al. (2010) EAU guidelines on renal cell carcinoma: the 2010 update. Eur Urol 58: 398-406.
3. Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, et al. (2006) A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A 103: 2257-2261.
4. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, et al. (2008) Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A 105: 10513-10518.
5. Chim SS, Shing TK, Hung EC, Leung TY, Lau TK, et al. (2008) Detection and characterization of placental microRNAs in maternal plasma. Clin Chem 54: 482-490.
6. Hunter MP, Ismail N, Zhang X, Aguda BD, Lee EJ, et al. (2008) Detection of microRNA expression in human peripheral blood microvesicles. PLoS One 3.
7. Mahn R, Heukamp LC, Rogenhofer S, von Ruecker A, Muller SC, et al. (2011) Circulating microRNAs (miRNA) in Serum of Patients With Prostate Cancer. Urology 77: 1265-1265.
8. Huang Z, Huang D, Ni S, Peng Z, Sheng W, et al. (2010) Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer. Int J Cancer 127: 118-126.
9. Heneghan HM, Miller N, Lowery AJ, Sweeney KJ, Newell J, et al. (2010) Circulating microRNAs as novel minimally invasive biomarkers for breast cancer. Ann Surg 251: 499-505.
10. Brase JC, Johannes M, Schlomm T, Falth M, Haese A, et al. (2011) Circulating miRNAs are correlated with tumor progression in prostate cancer. Int J Cancer 128: 608-616.
11. Chen X, Ba Y, Ma L, Cai X, Yin Y, et al. (2008) Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 18: 997-1006.
12. Lawrie CH, Gal S, Dunlop HM, Pushkaran B, Liggins AP, et al. (2008) Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma. Br J Haematol 141: 672-675.
13. Ng EK, Chong WW, Jin H, Lam EK, Shin VY, et al. (2009) Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening. Gut 58: 1375-1381.
14. Resnick KE, Alder H, Hagan JP, Richardson DL, Croce CM, et al. (2009) The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform. Gynecol Oncol 112: 55-59.
15. Tsujiura M, Ichikawa D, Komatsu S, Shiozaki A, Takeshita H, et al. (2010) Circulating microRNAs in plasma of patients with gastric cancers. Br J Cancer 102: 1174-1179.
16. Gottardo F, Liu CG, Ferracin M, Calin GA, Fassan M, et al. (2007) Micro-RNA profiling in kidney and bladder cancers. Urol Oncol 25: 387-392.
17. Nakada C, Matsuura K, Tsukamoto Y, Tanigawa M, Yoshimoto T, et al. (2008) Genome-wide microRNA expression profiling in renal cell carcinoma: significant down-regulation of miR-141 and miR-200c. J Pathol 216: 418-427.
18. Jung M, Mollenkopf HJ, Grimm C, Wagner I, Albrecht M, et al. (2009) MicroRNA profiling of clear cell renal cell cancer identifies a robust signature to define renal malignancy. J Cell Mol Med 13: 3918-3928.
19. Huang Y, Dai Y, Yang J, Chen T, Yin Y, et al. (2009) Microarray analysis of microRNA expression in renal clear cell carcinoma. Eur J Surg Oncol 35: 1119-1123.
20. Petillo D, Kort EJ, Anema J, Furge KA, Yang XJ, et al. (2009) MicroRNA profiling of human kidney cancer subtypes. Int J Oncol 35: 109-114.
21. Yi Z, Fu Y, Zhao S, Zhang X, Ma C, (2010) Differential expression of miRNA patterns in renal cell carcinoma and nontumorous tissues. J Cancer Res Clin Oncol 136: 855-862.
22. Juan D, Alexe G, Antes T, Liu H, Madabhushi A, et al. (2010) Identification of a microRNA panel for clear-cell kidney cancer. Urology 75: 835-841.
23. Chow TF, Youssef YM, Lianidou E, Romaschin AD, Honey RJ, et al. (2010) Differential expression profiling of microRNAs and their potential involvement in renal cell carcinoma pathogenesis. Clin Biochem 43: 150-158.
24. Youssef YM, White NM, Grigull J, Krizova A, Samy C, et al. (2011) Accurate Molecular Classification of Kidney Cancer Subtypes Using MicroRNA Signature. Eur Urol 59: 721-730.
25. White NM, Bao TT, Grigull J, Youssef YM, Girgis, A, et al. (2011) miRNA Profiling for Clear Cell Renal Cell Carcinoma: Biomarker Discovery and Identification of Potential Controls and Consequences of miRNA Dysregulation. J Urol 186: 1077-1083.
26. Ellinger J, El Kassem N, Heukamp LC, Mathews S, Cubukluoz F, et al. (2008) Hypermethylation of cell-free serum DNA indicates worse outcome in patients with bladder cancer. J Urol 179: 346-352.
27. Ellinger J, Bastian PJ, Haan KI, Heukamp LC, Buettner R, et al. (2008) Noncancerous PTGS2 DNA fragments of apoptotic origin in sera of prostate cancer patients qualify as diagnostic and prognostic indicators. Int J Cancer 122: 138-143.
28. Ellinger J, Haan K, Heukamp LC, Kahl P, Buttner R, et al. (2008) CpG Island hypermethylation in cell-free serum DNA identifies patients with localized prostate cancer. Prostate 68: 42-49.
29. Ellinger J, Albers P, Perabo FG, Muller SC, von Ruecker A, et al. (2009) CpG Island Hypermethylation of cell-free circulating serum DNA in patients with testicular cancer. J Urol 182: 324-329.
30. Dweep H, Sticht C, Pandey P, Gretz N, (2011) miRWalk- Database: Prediction of possible miRNA binding sites by "walking" the genes of three genomes. J Biomed Inform.
31. Moreira JM, Ohlsson G, Gromov P, Simon R, Sauter G, et al. (2010) Bladder cancer-associated protein, a potential prognostic biomarker in human bladder cancer. Mol Cell Proteomics 9: 161-177.
32. Kroh EM, Parkin RK, Mitchell PS, Tewari M, (2010) Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR). Methods 50: 298-301.